Charles Gayer
Corporate Officer/Principal presso BIOCRYST PHARMACEUTICALS, INC.
Patrimonio netto: 2 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Charles Gayer
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 37 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Charles Gayer tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Founder | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Sales & Marketing | |
| POWERSECURE INTERNATIONAL, INC. | Electrical Products | Investor Relations Contact | |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ENDO INTERNATIONAL PLC | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| Wake Forest University | College/University | Undergraduate Degree Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Masters Business Admin Undergraduate Degree | |
| London South Bank University | College/University | Undergraduate Degree | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member Director/Board Member | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Director/Board Member Corporate Officer/Principal | |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Astra Pharmaceuticals, Inc. | General Counsel | ||
| CLEARSIDE BIOMEDICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Sarcoma Foundation of America | Investment Trusts/Mutual Funds | Founder | |
| North Carolina Glaxosmithkline Foundation | Chairman Director/Board Member | ||
| Ealing Hammersmith & West London College | College/University | Graduate Degree | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
Royal Melbourne Hospital
 Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Hospital/Nursing Management | Corporate Officer/Principal | |
| MELINTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Thirona Bio, Inc.
 Thirona Bio, Inc. Pharmaceuticals: MajorHealth Technology Thirona Bio, Inc. is an American biopharmaceutical company that focuses on developing drugs for fibrotic diseases. Thirona Bio is based in an undisclosed location. The private company's target indications include scleroderma, keloid scars, and certain cancers where there are no effective therapies. The company's unique approach uses a potent, topically applied drug to inhibit TGF-? "locally," minimizing the potential risk of systemic toxicity. The company was founded by John Gordon Foulkes, Jay Edward Birnbaum, K. George Mooney, and David A. Bullough, with John Gordon Foulkes serving as the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 45 |
| Regno Unito | 3 |
| Irlanda | 2 |
| Germania | 2 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 182 |
| Corporate Officer/Principal | 101 |
| Independent Dir/Board Member | 71 |
| Chairman | 44 |
| Undergraduate Degree | 33 |
Contatti più connessi
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Robert Alexander Ingram | 43 |
| Kenneth Lee | 40 |
| George Abercrombie | 26 |
| Stephen Aselage | 20 |
| Nancy Hutson | 19 |
| Steven Galson | 17 |
| Alan Levin | 17 |
| Theresa Heggie | 16 |
| Vin Milano Milano | 14 |
| A. Sanders | 11 |
| Sanj Patel | 11 |
| Stanley Erck | 10 |
| Jon Stonehouse | 10 |
| Lynne Powell | 8 |
- Borsa valori
- Insiders
- Charles Gayer
- Connessioni Società
